Acute urinary retention (AUR) is an important complication of benign prostatic hyperplasia (BPH) and can affect 0.4-25% of men seen in urological practice each year. AUR is also one of the main indications for surgery, being the presenting features of 25-30% of transurethral resection of the prostate (TURP). However, TURP conducted under these conditions is associated with higher morbidity. A number of risk factors for AUR have been identified including severity of LUTS, reduced peak flow rate, prostate volume, post-void residual volume (PVR) and old age. Medical therapy for BPH can impact on prostate size, increased PVR and previous AUR episodes. Finasteride has been shown to reduce prostate size and consequently reduce the risk of AUR. St...
Item does not contain fulltextOBJECTIVE: To investigate whether there is a difference in the risk of...
Purpose: The medical treatment for benign prostatic hyperplasia (BPH) had recently been directed at ...
A significant change has occurred in the management of symptomatic benign prostatic hyperplasia (BPH...
Acute urinary retention (AUR) is one of the most significant, uncomfortable and inconvenient event i...
Benign prostatic hyperplasia (BPH) is a disease that affects over 50% of males aged 50 years or old...
Objective: To analyze patients ’ status and current practice in the management of acute urinary rete...
Background: Acute urinary retention (AUR) is one of the most significant complications or long-term ...
Objective: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
INTRODUCTION : Benign prostatic hyperplasia (BPH), one of the most common diseases of aging men, ca...
OBJECTIVES: To evaluate the management of acute urinary retention (AUR) associated with benign prost...
Background: Benign prostatic hyperplasia (BPH) is a non malignant enlargement of the prostate. This ...
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower ...
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower ...
Objective: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
OBJECTIVE: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
Item does not contain fulltextOBJECTIVE: To investigate whether there is a difference in the risk of...
Purpose: The medical treatment for benign prostatic hyperplasia (BPH) had recently been directed at ...
A significant change has occurred in the management of symptomatic benign prostatic hyperplasia (BPH...
Acute urinary retention (AUR) is one of the most significant, uncomfortable and inconvenient event i...
Benign prostatic hyperplasia (BPH) is a disease that affects over 50% of males aged 50 years or old...
Objective: To analyze patients ’ status and current practice in the management of acute urinary rete...
Background: Acute urinary retention (AUR) is one of the most significant complications or long-term ...
Objective: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
INTRODUCTION : Benign prostatic hyperplasia (BPH), one of the most common diseases of aging men, ca...
OBJECTIVES: To evaluate the management of acute urinary retention (AUR) associated with benign prost...
Background: Benign prostatic hyperplasia (BPH) is a non malignant enlargement of the prostate. This ...
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower ...
Benign prostatic hyperplasia (BPH) is the most common condition in aging men, associated with lower ...
Objective: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
OBJECTIVE: To investigate whether there is a difference in the risk of progressing to BPH-related pr...
Item does not contain fulltextOBJECTIVE: To investigate whether there is a difference in the risk of...
Purpose: The medical treatment for benign prostatic hyperplasia (BPH) had recently been directed at ...
A significant change has occurred in the management of symptomatic benign prostatic hyperplasia (BPH...